[go: up one dir, main page]

BG92179A - Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения - Google Patents

Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения

Info

Publication number
BG92179A
BG92179A BG092179A BG9217990A BG92179A BG 92179 A BG92179 A BG 92179A BG 092179 A BG092179 A BG 092179A BG 9217990 A BG9217990 A BG 9217990A BG 92179 A BG92179 A BG 92179A
Authority
BG
Bulgaria
Prior art keywords
intermediate compounds
enoic
hept
derivatives
substituted
Prior art date
Application number
BG092179A
Other languages
English (en)
Other versions
BG60555B1 (en
Inventor
Kau-Ming Chen
Prasad Kapa
George Lee
Oljan Repic
Petr Hess
Michel Crevoisier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26945992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG92179(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BG92179A publication Critical patent/BG92179A/bg
Publication of BG60555B1 publication Critical patent/BG60555B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
    • C07C223/02—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)

Abstract

Методът и съединенията ще се използват във фармацевтичната промишленост за производство на лекарствени средства с антисклеротичен и антихиперхолестеролемичен ефект. По метода се получава съединение с формула и съединение с формула в рацемична или в оптически чиста форма, под формата на свободна киселина, сол, естер или -лактон, както и други междинни съединения. 20 претенции
BG92179A 1988-10-13 1990-06-07 Method for the preparation of 7-substituted-hept-6-ennoic and intermediate compounds BG60555B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25747588A 1988-10-13 1988-10-13
US35553189A 1989-05-22 1989-05-22
PCT/EP1989/001201 WO1990003962A1 (en) 1988-10-13 1989-10-11 Process for the preparation of 7-substituted-hept-6-enoic and -heptanoic acids and derivatives and intermediates thereof

Publications (2)

Publication Number Publication Date
BG92179A true BG92179A (bg) 1993-12-24
BG60555B1 BG60555B1 (en) 1995-08-28

Family

ID=26945992

Family Applications (1)

Application Number Title Priority Date Filing Date
BG92179A BG60555B1 (en) 1988-10-13 1990-06-07 Method for the preparation of 7-substituted-hept-6-ennoic and intermediate compounds

Country Status (24)

Country Link
EP (2) EP0363934B1 (bg)
JP (1) JP2853227B2 (bg)
KR (1) KR0162656B1 (bg)
AT (1) ATE99281T1 (bg)
AU (1) AU636122B2 (bg)
BG (1) BG60555B1 (bg)
CA (1) CA2000553C (bg)
CZ (1) CZ283316B6 (bg)
DE (1) DE68911834T2 (bg)
DK (1) DK175073B1 (bg)
ES (1) ES2060712T3 (bg)
FI (1) FI98063C (bg)
HK (1) HK49496A (bg)
HU (1) HU207993B (bg)
IE (2) IE940109L (bg)
IL (1) IL91941A (bg)
MY (1) MY105067A (bg)
NO (1) NO174623C (bg)
NZ (1) NZ230973A (bg)
RO (1) RO109732B1 (bg)
SG (1) SG139553A1 (bg)
SK (1) SK579789A3 (bg)
WO (1) WO1990003962A1 (bg)
YU (1) YU48466B (bg)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118853A (en) * 1988-10-13 1992-06-02 Sandoz Ltd. Processes for the synthesis of 3-disubstituted aminoacroleins
US5290946A (en) * 1988-10-13 1994-03-01 Sandoz Ltd. Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes
CA2027179A1 (en) * 1989-10-10 1991-04-11 Barry C. Ross Chemical compounds
DE4424525A1 (de) * 1994-07-12 1995-01-26 Elmar Meyer Dauermagnet-Kolbenmotor
GT199800127A (es) 1997-08-29 2000-02-01 Combinaciones terapeuticas.
IL148127A0 (en) 1999-08-30 2002-09-12 Aventis Pharma Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
JP2003535077A (ja) 2000-05-26 2003-11-25 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド インドール誘導体を製造する方法、および該方法の中間体
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
WO2004094377A1 (ja) * 2003-04-24 2004-11-04 Daicel Chemical Industries Ltd. 光学活性なジヒドロキシヘプテン酸エステルの分離方法
ATE417827T1 (de) 2003-06-18 2009-01-15 Teva Pharma Fluvastatin-natrium in der kristallform xiv, verfahren zu deren herstellung, diese enthaltende zusammensetzungen und enstprechende anwendungsverfahren
US7368581B2 (en) 2003-06-18 2008-05-06 Teva Pharmaceutical Industries Ltd. Process for the preparation of fluvastatin sodium crystal from XIV
US7368468B2 (en) 2003-06-18 2008-05-06 Teva Pharmaceutical Industries Ltd. Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them
US8415364B2 (en) 2003-11-26 2013-04-09 Duke University Method of preventing or treating glaucoma
US7851624B2 (en) 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
US20060211752A1 (en) 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP1847529B1 (en) 2006-04-20 2009-05-20 F.I.S. Fabbrica Italiana Sintetici S.P.A. Process for the preparation of Fluvastatin Sodium salt
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
WO2010069593A1 (en) 2008-12-19 2010-06-24 Krka, D. D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
AU2013214693B2 (en) 2012-02-02 2017-02-23 Kenneth Gek-Jin OOI Improvements in tear film stability
RU2618628C1 (ru) 2013-04-17 2017-05-05 Пфайзер Инк. Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB945536A (en) * 1961-09-08 1964-01-02 Istituto Chemioterapico Method of preparing ª -amino-acroleins
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU204253B (en) * 1982-11-22 1991-12-30 Sandoz Ag Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
US4571428A (en) * 1983-07-08 1986-02-18 Sandoz, Inc. 6-Substituted-4-hydroxy-tetrahydropyran-2-ones
US4650890A (en) * 1984-04-03 1987-03-17 Sandoz Corp. Preparation of olefinic compounds and intermediates thereof
DE3582674D1 (de) * 1984-06-22 1991-05-29 Sandoz Ag Pyrazolanaloge von mevalonolakton und abkoemmlinge davon, verfahren zu deren herstellung und deren verwendung.
ATE60571T1 (de) * 1984-12-04 1991-02-15 Sandoz Ag Inden-analoga von mevalonolakton und ihre derivate.
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
JPS6322056A (ja) * 1986-04-30 1988-01-29 サンド・アクチエンゲゼルシヤフト オレフイン性化合物の製造法
PT85662B (pt) * 1986-09-10 1990-06-29 Sandoz Sa Processo para a preparacao de derivados de aza-indol e de indolizina e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
ES2060712T3 (es) 1994-12-01
IE63477B1 (en) 1995-04-19
YU197389A (en) 1990-12-31
AU4344889A (en) 1990-05-01
DK144690D0 (da) 1990-06-13
ATE99281T1 (de) 1994-01-15
KR900701723A (ko) 1990-12-04
FI902935A0 (fi) 1990-06-12
HK49496A (en) 1996-03-29
WO1990003962A1 (en) 1990-04-19
AU636122B2 (en) 1993-04-22
DK144690A (da) 1990-06-13
KR0162656B1 (ko) 1999-01-15
SG139553A1 (en) 2008-02-29
IL91941A0 (en) 1990-06-10
JPH03501735A (ja) 1991-04-18
DK175073B1 (da) 2004-05-24
IL91941A (en) 1994-10-21
DE68911834T2 (de) 1994-06-23
CZ283316B6 (cs) 1998-02-18
NO174623C (no) 1994-06-08
NO174623B (no) 1994-02-28
RO109732B1 (ro) 1995-05-30
JP2853227B2 (ja) 1999-02-03
NZ230973A (en) 1993-03-26
BG60555B1 (en) 1995-08-28
SK280845B6 (sk) 2000-08-14
HUT53860A (en) 1990-12-28
MY105067A (en) 1994-07-30
HU207993B (en) 1993-07-28
EP0363934B1 (en) 1993-12-29
CZ579789A3 (en) 1997-11-12
EP0562643A2 (en) 1993-09-29
DE68911834D1 (de) 1994-02-10
NO902598L (no) 1990-08-07
EP0562643A3 (en) 1994-05-18
FI98063C (fi) 1997-04-10
CA2000553A1 (en) 1990-04-13
SK579789A3 (en) 2000-08-14
YU48466B (sh) 1998-08-14
CA2000553C (en) 2001-12-04
EP0363934A1 (en) 1990-04-18
FI98063B (fi) 1996-12-31
NO902598D0 (no) 1990-06-12
HU896048D0 (en) 1990-11-28
IE893277L (en) 1990-04-13
IE940109L (en) 1990-04-13

Similar Documents

Publication Publication Date Title
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
BG49825A3 (bg) Метод за получаване на 10-дихидро-10-деоксо- 11-азаеритронолиди а
CS782686A2 (en) Method of benzimidazole derivatives production
ES2070994T3 (es) Profarmaco de dopamina.
SE8605063D0 (sv) Derivatives of cyclohexane
EP0614913A3 (en) Dynorphin derivatives.
RU93049997A (ru) Производные метилен-бис-фосфоновой кислоты, способ их получения, фармацевтическая композиция
CA2047744A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
IE45439L (en) Penicillanic acid derivatives
FR2448535A1 (fr) Nouveaux derives tricycliques et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
NO301767B1 (no) Salt av clavulansyre
DE3688087D1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
FR2663328B1 (fr) Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0546177A4 (en) BENZOPYRANE DERIVATIVE, PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME.
FI890477A (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,5-diamino-6-fluoriheksaanihapon ja sen suolojen valmistamiseksi
FI864970A0 (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
NO883520D0 (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
NO177484C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler
BG47648A3 (bg) Метод за получаване на триазолилхинолинови съединения
DE69016087D1 (de) Stabile Lösungen von Rebeccamycinderivaten sowie deren Herstellung.
HUT62855A (en) Process for producing glycerol derivatives and pharmaceutical compositions comprising same
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
ATE120731T1 (de) Optisch aktives derivat der d-2-(6-methoxy-2- naphthyl)-propionsäure und es enthaltende pharmazeutische zusammensetzungen.
WO1987004435A3 (en) Xanthine compounds